Vasi Naganathan

Vasi Naganathan

Auto-generated profile, based on publicly available information

Vasi Naganathan

Faculty of Medicine and Health, Concord Clinical School, The University of Sydney, Sydney, Australia

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
DGDanijela Gnjidic
Danijela Gnjidic
SHSarah N. Hilmer
Sarah N. Hilmer
FBFiona M. Blyth
Fiona M. Blyth
VNVasi Naganathan
Vasi Naganathan
LWLouise Waite
Louise Waite
DCDavid G. Le Couteur
David G. Le Couteur

4 November 2010 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
NHNoran Naqiah Hairi
Noran Naqiah Hairi
RCRobert G. Cumming
Robert G. Cumming
VNVasi Naganathan
Vasi Naganathan
DHDavid J. Handelsman
David J. Handelsman
DCDavid G. Le Couteur
David G. Le Couteur
PSPhilip N. Sambrook
Philip N. Sambrook

1 January 2008 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
SIShoba Iyer
Shoba Iyer
VNVasi Naganathan
Vasi Naganathan
AMAndrew J. McLachlan
Andrew J. McLachlan
DCDavid G. Le Conteur
David G. Le Conteur

3 June 2016 in BMJ
Verified
Journal Article
Open access
PDF file
JJJesse Jansen
Jesse Jansen
VNVasi Naganathan
Vasi Naganathan
SCStacy M Carter
Stacy M Carter
AMAndrew J McLachlan
Andrew J McLachlan
Brooke NickelBrooke Nickel
Brooke Nickel
KMKirsten McCaffery
Kirsten McCaffery
Jansen and colleagues explore the role of shared decision making in tackling inappropriate polypharmacy in older adults

1 February 2012 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
DGDanijela Gnjidic
Danijela Gnjidic
SHS N Hilmer
S N Hilmer
FBF M Blyth
F M Blyth
VNV Naganathan
V Naganathan
RCR G Cumming
R G Cumming
DCD G Le Couteur
D G Le Couteur

8 December 2016 in Age and Ageing
Verified
Journal Article
Closed access
PDF file
VHVasant Hirani
Vasant Hirani
VNVasi Naganathan
Vasi Naganathan
FBFiona Blyth
Fiona Blyth
DCDavid G. Le Couteur
David G. Le Couteur
MSMarkus J. Seibel
Markus J. Seibel
RCRobert G. Cumming
Robert G. Cumming
To explore the longitudinal associations between body composition measures, sarcopenic obesity and outcomes of frailty, activities of daily living (ADL) and instrumental ADL (IADL) disability, institutionalisation and mortality. men aged ≥ 70 years (2005–07) from the Concord Health and Ageing in Men Project were assessed at baseline (n = 1,705), 2 (n = 1,366) and 5 years (n = 954). The main outcome measures were frailty (adapted Fried criteria), ADL, including personal care and mobility and IADL disability (ability to perform tasks for independent living), institutionalisation and mortality. The Foundation for the National Institutes of Health cut-points were used for low muscle mass: appendicular lean mass (ALM):Body Mass Index (BMI) ratio (ALMBMI) 30% fat. Generalised estimating equations were used to examine the longitudinal associations between the independent variables (obesity alone, low muscle mass and sarcopenic obesity) and frailty, ADL and IADL disability. in unadjusted, age adjusted and fully adjusted analysis, men with low muscle mass showed increased risk of frailty and IADL disability. In fully adjusted analysis, men with sarcopenic obesity had an increased risk of frailty (odds ratio (OR): 2.00 (95% confidence of interval (CI): 1.42, 2.82)) ADL disability (OR: 1.58 (95% CI: 1.12, 2.24)) and IADL disability (OR: 1.36 (95% CI: 1.05, 1.76)). Obesity alone was protective for institutionalisation (OR: 0.51 (95% CI: 0.31, 0.84)) but was not associated with any other outcomes. low muscle mass and sarcopenic obesity were associated with poor functional outcomes, independent of confounders. This would suggest that future trials on frailty and disability prevention should be designed to intervene on both muscle mass and fat mass.